Treating alzheimer's disease utilizing a laser
AssigneesArizona Board of Regents on behalf of Arizona State University, Halberd Corporation
InventorsQiang Chen, Mitchell Steven Felder
Life of this patent
Estimating the term…
Abstract
An embodiment provides a method for treating a body fluid of a patient with Alzheimer's Disease, including: removing the body fluid from a patient; applying a treatment to the body fluid, wherein the treatment comprises an antibody that joins with an Alzheimer's targeted antigen (TA) in the body fluid to form an antibody-TA complex, wherein the antibody comprises a tag sensitive to an illumination; removing the antibody-TA complex from the body fluid using an illumination source; and returning the body fluid to the patient. Other aspects are described and claimed.
Claims20
A method for treating a body fluid of a patient with Alzheimer's Disease, comprising:
- removing the body fluid from a patient;
- applying a treatment to the body fluid, wherein the treatment comprises an antibody that joins with an Alzheimer's targeted antigen (TA) in the body fluid to form an antibody-TA complex, wherein the antibody comprises a tag sensitive to an illumination;
- removing the antibody-TA complex from the body fluid using an illumination source;
- and
- returning the body fluid to the patient.
A device for treating a body fluid of a patient with Alzheimer's Disease, comprising:
- a transparent first stage including an inlet for the body fluid and at least one exterior wall defining a treatment chamber;
- a transparent second stage, fluidly connected to the first stage, comprising a removal module and an outlet for the body fluid, wherein the treatment chamber comprises a delivery tube for introducing an antibody into the treatment chamber, wherein the delivery tube comprises a hollow tube including at least one interior wall defining a plurality of holes through which the antibody can be added to the treatment chamber, wherein the treatment is delivered through the hollow tube in counter-current mode with reference to the body fluid;
- and
- an illumination source;
- the device being configured to:
- remove the body fluid from a patient;
- apply a treatment to the body fluid, wherein the treatment comprises the antibody that joins with a target antigen (TA) in the body fluid to form an antibody-Alzheimer's Disease targeted antigen (TA) complex, wherein the antibody comprises a tag sensitive to an illumination;
- remove the antibody-TA complex from the body fluid using the illumination source;
- and
- return the body fluid to the patient.
A product for treating a body fluid of a patient with Alzheimer's Disease, comprising:
- a transparent first stage including an inlet for the body fluid and at least one exterior wall defining a treatment chamber;
- a transparent second stage, fluidly connected to the first stage, comprising a removal module and an outlet for the body fluid, wherein the treatment chamber comprises a delivery tube for introducing an antibody into the treatment chamber, wherein the delivery tube comprises a hollow tube including at least one interior wall defining a plurality of holes through which the antibody can be added to the treatment chamber, wherein the treatment is delivered through the hollow tube in counter-current mode with reference to the body fluid, wherein the treatment comprises an antibody that joins with an Alzheimer's targeted antigen (TA) in the body fluid to form an antibody-TA complex, wherein the antibody comprises a tag sensitive to an illumination;
- and
- a laser illumination source.
Dependencies are inferred from the claim text.